ARTICLE | Company News
Gyroscope-led consortium gets UK funding for cost-effective manufacture of AAV gene therapies
November 16, 2018 7:45 PM UTC
A consortium led by retinal gene therapy company Gyroscope Therapeutics Ltd. (Stevenage, U.K.) received a two-year, £1.1 million ($1.4 million) award from Innovate UK to develop a manufacturing platform for production of adeno-associated virus (AAV) gene therapies.
The consortium plans to develop a shared, scalable suspension platform for cost-effective manufacture of new AAV gene therapies...